Pharmacogenetics May Prevent Psychotropic Adverse Events in Autism Spectrum Disorder: An Observational Pilot Study

Pharmacogenetics May Prevent Psychotropic Adverse Events in Autism Spectrum Disorder: An Observational Pilot Study

Introduction: Up to 73% of individuals with autism spectrum disorder (ASD) and intellectual disability (ID) currently have prescriptions for psychotropic drugs. This is explained by a higher prevalence of medical and psychiatric chronic comorbidities, which favors polypharmacy, increasing the probab...

Full description

Bibliographic Details
Main Authors: Laura de Miguel, Pura Ballester, Cecilia Egoavil, María Luisa Sánchez-Ocaña, Ana María García-Muñoz, Begoña Cerdá, Pilar Zafrilla, Enrique Ramos, Ana M. Peiró
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Pharmaceuticals
Subjects:
autism spectrum disorder
pharmacogenetics
adverse events
polypharmacy
dopaminergic system
Online Access:https://www.mdpi.com/1424-8247/16/10/1496

Internet

https://www.mdpi.com/1424-8247/16/10/1496

Similar Items